Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1993 1
1995 2
1996 9
1997 6
1998 5
1999 1
2000 1
2001 4
2002 5
2003 6
2004 16
2005 17
2006 14
2007 19
2008 23
2009 14
2010 11
2011 6
2012 12
2013 14
2014 12
2015 17
2016 16
2017 13
2018 15
2019 9
2020 19
2021 16
2022 20
2023 22
2024 23
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases.
Evans LS, Lewis KE, DeMonte D, Bhandari JG, Garrett LB, Kuijper JL, Ardourel D, Wolfson MF, Debrot S, Mudri S, Kleist K, Griffin LL, Hebb L, Sanderson RJ, Wang N, Seaberg M, Chunyk AG, Yang J, Hong Y, Maria Z, Messenheimer DJ, Holland PM, Peng SL, Rixon MW, Dillon SR. Evans LS, et al. Among authors: peng sl. Arthritis Rheumatol. 2023 Jul;75(7):1187-1202. doi: 10.1002/art.42462. Epub 2023 Apr 19. Arthritis Rheumatol. 2023. PMID: 36705554
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults.
Davies R, Peng SL, Lickliter J, McLendon K, Enstrom A, Chunyk AG, Blanchfield L, Wang N, Blair T, Thomas HM, Smith A, Dillon SR. Davies R, et al. Among authors: peng sl. Clin Transl Sci. 2024 Nov;17(11):e70055. doi: 10.1111/cts.70055. Clin Transl Sci. 2024. PMID: 39494621 Free PMC article. Clinical Trial.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: peng sl. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Progress on plant orphan genes.
Jiang ML, Lang H, Li XN, Zu Y, Zhao J, Peng SL, Liu Z, Zhan ZX, Piao ZY. Jiang ML, et al. Among authors: peng sl. Yi Chuan. 2022 Aug 20;44(8):682-694. doi: 10.16288/j.yczz.22-154. Yi Chuan. 2022. PMID: 36384667 Review.
Editorial: Artificial Intelligence for eHealth.
Gupta D, Rodrigues JJPC, Peng SL, Nguyen N. Gupta D, et al. Among authors: peng sl. Front Public Health. 2022 Mar 4;10:852840. doi: 10.3389/fpubh.2022.852840. eCollection 2022. Front Public Health. 2022. PMID: 35309212 Free PMC article. No abstract available.
International Evidence-Based Guidelines for Traditional Chinese Medicine Management of Allergic Rhinitis.
Fu QW, Liu P, Ruan Y, Li XR, Zhang LZ, Yang SS, Chai F, Chen J, Chen QY, Chen SC, Chen WY, Chen YN, Cheng HB, Cheng L, Cui LJ, Deng KB, Fang CS, Feng RC, Fu L, Fu WY, Gao JY, Guo H, He M, Hu KH, Huang CJ, Huang HY, Jiang LY, Qiao FY, Leng H, Li YY, Liu CS, Liu DX, Liu JH, Liu JH, Liu J, Liu M, Liu WT, Liu YX, Liu Y, Liu Y, Liu ZQ, Luo QL, Ma Y, Mao DH, Meng J, Pang KY, Peng SL, Tong XF, Wang J, Wang JX, Wang JG, Wang RZ, Wang SZ, Xia JY, Xie H, Xie Q, Xie Y, Xiong DJ, Yan ZF, Yang H, Zhang DZ, Zhang FB, Zhang SP, Zhang ZC, Zhao JP, Zhao Y, Zheng Y, Zhong DZ, Zhou L, Knyazev VM, Kostrova IV, Yeung WF, Wang Q, Wang DY, Zhang QX. Fu QW, et al. Among authors: peng sl. Allergy. 2025 Sep 13. doi: 10.1111/all.70057. Online ahead of print. Allergy. 2025. PMID: 40944470
344 results